Provided by Tiger Trade Technology Pte. Ltd.

Health Care Select Sector SPDR Fund

167.66
-0.0900-0.05%
Post-market: 167.900.2400+0.14%19:48 EDT
Volume:7.43M
Turnover:1.24B
Market Cap:43.54B
PE:-11.79
High:168.20
Open:167.79
Low:166.18
Close:167.75
52wk High:176.60
52wk Low:133.73
Shares:259.67M
Float Shares:259.67M
Volume Ratio:0.86
T/O Rate:2.86%
Dividend:2.53
Dividend Rate:1.51%
EPS(TTM):-14.2170
EPS(LYR):-14.2170
ROE:-9.22%
ROA:1.03%
PB:1.27
PE(LYR):-11.79

Loading ...

Bamboos Health Care Warns of Sharp Profit Decline Amid Competitive and Cost Pressures

TIPRANKS
·
Sep 09

Market Chatter: UnitedHealth Sells Stake in Florida Optum Health Operations to TPG

MT Newswires Live
·
Sep 09

Health Care Roundup: Market Talk

Dow Jones
·
Sep 09

HealthCo REIT Director Increases Stake Under Board Unit Plan

TIPRANKS
·
Sep 09

Fisher & Paykel Healthcare Issues New Unquoted Employee Options

TIPRANKS
·
Sep 09

Analysts Conflicted on These Healthcare Names: Amgen (AMGN), Beam Therapeutics (BEAM) and Royalty Pharma (RPRX)

TIPRANKS
·
Sep 09

Ramsay Health Care (RMSYF) Receives a Sell from Ord Minnett

TIPRANKS
·
Sep 09

UnitedHealth Sells Interest in Florida Wellmed Clinics to TPG - Bloomberg News

THOMSON REUTERS
·
Sep 09

Health Care Down as Novartis, Boston Scientific Weigh - Health Care Roundup

Dow Jones
·
Sep 09

Tenet Healthcare Prices Upsized $2 Billion Notes Offering

MT Newswires Live
·
Sep 09

Molina Healthcare Inc. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Sep 09

Atai Beckley Holds Shareholder Meeting, Quorum Met with 65.6% Shares Represented

Reuters
·
Sep 09

Strata Critical to Present at the 2026 Jefferies Healthcare Services and Technology Conference

GlobeNewswire
·
Sep 09

Health Care Roundup: Market Talk

Dow Jones
·
Sep 09

Medtronic PLC Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Sep 09

UnitedHealth to Present Strategy at Wells Fargo Conference

TIPRANKS
·
Sep 09

Merck & Co. Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Sep 09

Protagonist Therapeutics Launches USD 300 Million Share Buyback Program

Reuters
·
Sep 09

Cycurion Secures New Healthcare and Public Health Contracts

TIPRANKS
·
Sep 09

Analyst Maintains Buy on Sarepta, Keeping $35 Price Target Amid Confidence in DM1 Franchise and α‑Integrin Delivery Platform

TIPRANKS
·
Sep 09